Boyrung Pharma’s hypertensive drug to be sold in Russia, Southeast Asia
Sept 26, 2016
[THE INVESTOR] Boryung Pharmaceutical announced on Sept. 26 that its high blood pressure treatment Kanarb is close to being approved for sale in Russia, Singapore and Malaysia.“Kanarb is expected to be granted permission in Russia in October, and in Singapore and Malaysia within this year. The official launch will be in the first half of 2017,” said Choi Seong-won, head of global business at the South Korean pharmaceutical company at a press conference in Seoul. The firm has partnered with Russi